PRCT - PROCEPT BioRobotics Corp
24.22
-1.130 -4.666%
Share volume: 2,416,368
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$25.35
-1.13
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-02-2024 | 10-28-2024 | 02-27-2025 | 05-02-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 382.900 M | 374.350 M | 374.142 M | 534.017 M | 519.375 M | 511.541 M | 508.081 M | |
| Current Assets | 329.186 M | 321.892 M | 322.981 M | 481.842 M | 465.791 M | 454.752 M | 450.378 M | |
| Inventories | 41.622 M | 43.865 M | 50.850 M | 56.168 M | 62.330 M | 66.715 M | 70.694 M | |
| Other Current Assets | 5.907 M | 5.017 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 5.907 M | 5.017 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 56.081 M | 58.917 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 225.576 M | 214.093 M | 196.762 M | 333.725 M | 316.207 M | 294.281 M | 286.503 M | |
| Total Non-current Assets | 53.714 M | 52.458 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 28.488 M | 27.675 M | 26.605 M | 26.709 M | 28.127 M | 30.022 M | 30.399 M | |
| Other Assets | 21.052 M | 20.677 M | 24.556 M | 25.466 M | 25.457 M | 26.767 M | 27.304 M | |
| Intangible Assets | 1.136 M | 1.068 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 382.900 M | 374.350 M | 374.142 M | 534.017 M | 519.375 M | 511.541 M | 508.081 M | |
| Total liabilities | 118.853 M | 122.571 M | 132.924 M | 131.797 M | 130.218 M | 131.265 M | 142.211 M | |
| Total current liabilities | 38.650 M | 42.845 M | 53.646 M | 53.133 M | 52.064 M | 53.898 M | 65.795 M | |
| Accounts Payable | 10.084 M | 9.950 M | 15.088 M | 10.032 M | 14.827 M | 11.118 M | 17.285 M | |
| Other liabilities | 517.000 K | 479.000 K | 27.840 M | 27.192 M | 26.656 M | 25.801 M | 24.801 M | |
| Current long term debt | 1.701 M | 1.769 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 79.686 M | 79.247 M | 51.438 M | 51.472 M | 51.498 M | 51.566 M | 51.615 M | |
| Other liabilities | 517.000 K | 479.000 K | 27.840 M | 27.192 M | 26.656 M | 25.801 M | 24.801 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 264.047 M | 251.779 M | 241.218 M | 402.220 M | 389.157 M | 380.276 M | 365.870 M | |
| Common stock | 51.011 M | 51.622 M | 768.365 M | 948.091 M | 959.656 M | 991.945 M | 1.007 B | |
| Retained earnings | -480.529 M | -506.155 M | -527.129 M | -545.985 M | -570.722 M | -611.711 M | -641.557 M |